Streptavidin - 20nm Silver Conjugate
Cytodiagnostics
SKU:SC-20-04-05
Couldn't load pickup availability

Streptavidin - 20nm Silver Conjugate for silver nanoparticle detection
Use Streptavidin - 20nm Silver Conjugate when your workflow needs reliable detection of biotinylated antibodies, probes and capture molecules in Immunoblotting, Light Microscopy and Electron Microscopy. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Where it helps
The silver nanoparticle label is useful when a bright silver-based optical readout is preferred over a traditional gold readout. The smaller silver label can be useful when epitope access, membrane flow or reduced steric load are important.
Planning the experiment
- Supports Immunoblotting, Light Microscopy and Electron Microscopy workflows where Streptavidin signal needs to be interpreted with appropriate controls.
- Useful when a biotinylated antibody, oligonucleotide or ligand should be converted into a nanoparticle-visible signal.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference SC-20-04-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. For protocol transfer, record the catalog reference together with the selected application and control strategy.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Nanotechnology & Biosensors
- Application:
- Immunoblotting • Light Microscopy • Electron Microscopy
- Host:
- Streptomyces Avidinii
- Formulation:
- 1XPBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 398-410nm
- Core Size:
- 20nm
- Shape:
- Spherical
- Material:
- Silver
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.